Introduction
In sub-Saharan Africa, the prevention of transfusion-transmitted HIV infection has been a priority for donor-supported blood safety programmes. In addition to recruiting safer blood donors and strengthening laboratory screening practices based on World Health Organization (WHO) guidelines [1, 2] , blood safety investments have also sought to improve availability of blood to reduce the risk of administering poorly screened or unscreened blood in life-threatening situations. While much has been done to quantify the risk of HIV transmission through blood transfusion [3] [4] [5] [6] [7] and identify successful risk-reduction strategies [8] [9] [10] [11] [12] , there is limited information about the impact that blood safety investments have had on improving the availability of blood in sub-Saharan Africa.
In Namibia, a country of approximately two million people in southern Africa, only the Blood Transfusion Service of Namibia (NAMBTS) can collect, process and distribute blood. All units are collected from voluntary, nonremunerated blood donors (VNRD), of which approximately 73% are repeat donors, a population shown to have lower infection risk for HIV than family and replacement donors [13] . In 2011, NAMBTS collected 23 338 whole blood units and distributed 99.9% of all units as blood components. Based on these totals, NAMBTS collected 11 units of whole blood per 1000 population, meeting a widely used blood collection target (10-20 whole blood units per 1000 population per year) for resource-limited countries [14] .
However, blood components have not been evenly distributed around the country.
Historically, collection and use of blood have been greatest in Namibia's three urban centres (Windhoek, the capital, and two cities on the Atlantic coast) that contain less than 20% of the national population. More than two-thirds of Namibia's population, and 50% of health facilities, are located in seven regions along the northern border with Angola [15] . The remaining population resides in four rural regions with low population density. (Fig. 1 ) Economic and health disparities exist between the regions. Up to 60% of residents in the populous northern regions are classified as 'poor' compared to only six per cent of Windhoek residents [16] . Overall infectious disease burdens in the north are also higher than in the capital [17, 18] . 
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of safe blood available for transfusion and to strengthen the national blood distribution system. Interventions included the development of an electronic inventory management database; launch of daily stock-management telephone calls with facilities; use of the national post's overnight delivery service; revision of national blood policies, guidelines and training programmes; procurement of cold chain and laboratory equipment; and renovation of blood banks and laboratories to enhance storage and capacity to perform ABO grouping and compatibility testing.
Reports have described PEPFAR's impact on key elements of national HIV/AIDS responses in sub-Saharan Africa, such as the prevention of mother-to-child transmission (PMTCT) and the reduction in HIV mortality due to increased use of antiretroviral therapy [19] [20] [21] . Studies have also evaluated the impact of WHO guidelines and strengthened laboratory systems on the safety of blood supplies in sub-Saharan Africa [9, [22] [23] [24] . However, studies examining the impact of PEPFAR support on the distribution of safe blood have not been conducted.
This study evaluated whether PEPFAR support improved the distribution of safe blood nationally in Namibia. The lessons from Namibia are important for other countries in the region and provide a unique glimpse into PEPFAR's impact on the adequacy of blood supplies in Africa.
Materials and methods
Data collection followed approval from the Namibian Ministry of Health and Social Services (MOHSS). Because the study involved the evaluation of routine public health programme data, it was exempted from review by an institutional review board by the U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Data on all blood and blood product units collected nationally and issued to a Namibian healthcare facility from January 1, 2003 to December 31, 2011 were analysed. To receive blood and blood products, physicians must submit a standardized national Blood Request Form (BRF) to hospital blood banks. Copies of all BRFs resulting in the issuance of blood units were returned to NAMBTS headquarters where data were entered into an electronic database. Information on BRFs that did not result in the issuance of blood units was not available.
Each BRF that resulted in the issue of blood units was considered to represent a 'transfusion event' in which any combination of blood or blood components was requested and issued to including diagnosis and haemoglobin level, only variables relevant to billing were routinely entered into the database. For this analysis, healthcare facility name, date of issue, and the number and type of blood components issued were reviewed. Clinical outcomes were not reported to NAMBTS, and data were not available to confirm that issued units were trans-fused. This analysis therefore only evaluated changes in the distribution of blood and blood components.
Annual blood collections data were derived from NAMBTS records and stratified by year and component type. The number of units issued to health facilities was stratified by year, region, facility and component type. Facilities were matched to regions and categorized as public, private or faith based. Records without a facility name were categorized as 'unknown' and were excluded from the regional analyses. Records for units issued by small facilities that did not issue blood in any two consecutive years from 2003 to 2011 were excluded. To show changes in availability of blood products over time and by place, Namibian census data were used to stratify Namibia's 13 regions into three regional categories: the seven most populous but largely under-developed regions in the north ('northern'), the two regions containing Windhoek and two cities on the Atlantic coast ('urban'), and four regions with small, rural populations ('rural') [15] . Population density was assessed spatially using data from the Global Rural-Urban Mapping Project (GRUMP; Columbia University, NY, NY).
The nine-year time frame was grouped into two multi-year periods, the 'early PEPFAR pe- 
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The greatest increases in availability in all three regional categories occurred during 2008-2011 period, the period of peak PEPFAR activity. (Fig. 3 In contrast, the annual number of transfusion events decreased in the northern and rural regions by 10% and 30%, respectively. In these regions, the increased number of WB-RCC units 
Conclusion
A recent report by the U.S. Institute of Medicine observed that while the distribution of blood remains a challenge in PEPFAR-supported countries, PEPFAR's investments in laboratory infrastructure and healthcare procurement systems had demonstrated positive 'spillover effects for [the] entire health system' [25] . This study examining the distribution of every blood unit issued in Namibia since the start of PEPFAR's blood safety project in Namibia describes an important example of this spillover effect. It also provides evidence that blood safety investments, which helped NAMBTS mobilize a low risk donor pool (HIV prevalence in donated units <1%) in a country with a high HIV population prevalence [24, 26] , can also be effective in addressing barriers to distribution. Investments in inventory management and laboratory infrastructure, coupled with a strong emphasis on distribution logistics and training clinicians on the appropriate clinical use of blood, resulted in a measurable increase in the quantity of red cell units requested and issued for transfusion in remote regions throughout the study period, especially during the period of peak PEPFAR support (2008) (2009) (2010) (2011) .
While these findings demonstrate improvements in availability of blood nationally, disparities persist between Namibia's urban centres and less-developed or rural regions where the majority of the population lives. These disparities are linked to a number of geographical, structural and socio-economic issues, but distance and challenges preserving the cold chain may be the biggest barriers to further improvements in distribution to nonurban areas. The concentration of the country's major public and private referral hospitals in the capital region also contributes to increased blood use in the urban regions. While access to specialist healthcare services is still uncommon in Africa, in Namibia, the national blood supply is increasingly used to treat patients with cancers and other blood disorders (unpublished blood utilization surveillance data, NAMBTS). Elsewhere in the region, as countries reach middle income status and continue to work towards the Millennium Development Goals in maternal and child health [27, 28] , similar changes in blood utilization patterns, which have traditionally been dominated by demand for malaria-associated anaemia in children and postpartum haemorrhage in pregnant women, may occur. This study is subject to the following limitations. First, the lack of data on transfusion outcomes limits the ability to describe a causal association between blood safety investments and health outcomes. Therefore, while Namibia invested in ambitious targets for maternal and child health during the study period [32] , we are unable to comment on whether any changes in childhood or maternal mortality in Namibia directly resulted from blood safety investments. Second, data on patient diagnoses were not available for all records, limiting the ability to evaluate the appropriateness of clinical blood use. Third, it was not possible to measure the impact of training and the introduction of new guidelines on changes in pre-scribing practices between clinicians. Fourth, although these data show improved distribution of blood components, they do not show whether the supply was able to meet the actual need for blood among hospitalized patients or among patients without access to healthcare facilities.
The sustainability of these accomplishments will require attention by NAMBTS and its external partners. PEPFAR support for NAMBTS peaked in 2009 and has continued to decline as PEPFAR's overall support to Namibia is reduced [33] . While NAMBTS has a cost recovery system and generates revenue through the sale of excess plasma, reduced PEPFAR support may result in higher unit costs or reduced investments in staff, training and equipment -or both. Despite an overall trend towards more equal distribution of RCC, increased consumption of blood components by private facilities and the concentration of platelets in two urban facilities also mirror continuing inequalities in healthcare access in Namibia described elsewhere [34] . As PEPFAR and other donors develop sustainable transition strategies, studies are needed to establish causal pathways between blood safety investments and patient outcomes and describe long-term economic benefits associated with investments in blood safety and blood transfusion services. Improved models to estimate the adequacy of national blood supplies in developing countries is also needed. Finally, the potential for blood safety investments to impact maternal health [35] and other indicators related to the Millennium Development Goals also merits continued attention.
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